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Background: Surgical site infection (SSI) is one of themost com-
mon and serious postoperative complications of modern surgery.
Contributes to themorbidity, mortality, duration of hospitalization
and increases the cost of treatment. In patients after surgery for
gastrointestinal SSI occur with a frequency of 10 - 30%.
The most common risk factors include: age, abdominal proce-
dure, duration of operation, timing of operation, surgical technique,
transfusion, blood loss, duration of operation, preoperative nutri-
tional status, parenteral nutrition, catheter use, diabetes, presence
of 1≥ concomitant diagnoses, ASA score.
The aim of this study was to develop a mathematical model
deﬁning the patients with the highest risk of bacterial and fungal
infection operated in the abdominal cavity.
Methods & Materials: Among the 1,567 patients operated in
the ﬁeld of abdominal cavity in 2010 year, 150 patients under-
went cholecystectomy, appendectomy, colorectal procedures had
developed SSI and has been chosen to analysis of risk factors. The
prospective study of fungi- infection consisted of 43 patients.We
have used the Bayesian methods to determine the factors that give
the highest probability of SSI.
Results: We have obtained a model of three-layer MLP network
with 7 input neurons and 2 hidden.
This neural model identiﬁed the most inﬂuential factors for SSI
as: age, mode of admission, postoperative diagnosis, peritonitis,
reoperation, ASA score and infection unrelated to the place of oper-
ation.
The obtained network as a predictive model allows more effec-
tively predict occurrence of SSI with 95% probability.
Bayesianmodel predicting fungal infections includes: age,mode
of admission,presenceofbacterial sepsis, numberof antibiotics and
timing of therapy, parenteral nutrition,more than one organ failure
and diabetes.
Conclusion: The most important factors related due to bacte-
rial SSI has 9 factors and has 95% probability of SSI. The model for
fungal infections includes 6 factors and predicts the occurrence of
infection with 87% of probability. The introduction of this model is
a new approach for the early identiﬁcation of patients at high risk
of bacterial and fungal infection.
http://dx.doi.org/10.1016/j.ijid.2014.03.1003
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Burden of serious fungal infections in Germany
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Background: The current number of fungal infections occurring
each year inGermany is not known.Wehave estimated these based
on populations at risk, supplemented with existing data.
Methods & Materials: All published epidemiology papers
reporting fungal infection rates from Germany were identiﬁed.
2011/12 population statistics (ICD10 coding) were derived from
the National Institute of Health (www.gbe-bund.de). HIV/AIDS and
tuberculosis cases (2011) were obtained from the relevant reg-
istries (www.rki.de).
Results: Of the 81.84M population (adults 65.47M; 41.64M
female), 20% are children (0-14 years) and 16% of population
are >65 years old. In a pan-European survey on fungal skin dis-
ease 33% of patients visiting a general practitioner had evidence
of superﬁcial fungal infection (SFI). From these data, it can be
calculated, 6,700,000 individuals suffer from SFI in Germany. Esti-
mates of recurrent vaginal candidosis (rVVC) prevalence in adult
woman are ∼9%, which correlates to 3,690,000 German women
with rVVC. In 682 ICU’, the ratio of albicans to non-albicans candi-
daemia is 381: 142 (63%vs. 37%)with a candidaemia rate calculated
at 4.7/100,000 inhabitants. Of the 4,317 cases of TB in 2011, mostly
inHIVnegative people, it is estimated that 479newcases of chronic
pulmonary aspergillosis (CPA) occurred post-TB. Assuming that TB
is the underlying disease in 20% of cases, the 5-year period preva-
lence will be ∼10,000 cases. Estimates of asthma prevalence in
adults are between 7-8% (in total 4.9M) and assuming 2.5% of
asthmatics have ABPA, 123,960 patients with ABPA are likely and
163,131withSAFS. Invasiveaspergillosis (IA; ICD10B44)was coded
in 1,595 hospitalized patients, many less than the 10% (n=1,671)
only in AML; usually 50% of the total IA caseload in haematology.
Of the 43,000 HIV positive patients, 5 (5%) of 280 new AIDS cases
each year develop cryptococcal meningitis. The annual incidence
of Pneumocystis jiroveciipneumonia is 1.2 cases/100,000 consistent
with 986 cases.
Conclusion: using local data and literature it can estimated that
almost 10.7M (9%) people inGermanysuffer from a fungal infec-
tion each year. Substantial uncertainty surrounds these estimates
because fungal infections do not belong to the notiﬁable transmis-
sible infectious diseases.
http://dx.doi.org/10.1016/j.ijid.2014.03.1004
